Kambiz Yazdi
Stock Analyst at BTIG
(4.46)
# 303
Out of 5,135 analysts
17
Total ratings
64.71%
Success rate
27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTVT vTv Therapeutics | Maintains: Buy | $40 → $49 | $37.23 | +31.61% | 2 | Jan 27, 2026 | |
| SION Sionna Therapeutics | Reiterates: Buy | $58 | $37.73 | +53.72% | 3 | Jan 14, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $507 → $843 | $328.93 | +156.29% | 5 | Dec 29, 2025 | |
| RAPP Rapport Therapeutics | Reiterates: Buy | $47 | $29.20 | +60.96% | 2 | Dec 8, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $15.00 | +53.33% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $26.71 | -28.87% | 2 | Mar 11, 2025 | |
| EYPT EyePoint | Initiates: Buy | $15 | $14.36 | +4.46% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.07 | +367.29% | 1 | Apr 12, 2024 |
vTv Therapeutics
Jan 27, 2026
Maintains: Buy
Price Target: $40 → $49
Current: $37.23
Upside: +31.61%
Sionna Therapeutics
Jan 14, 2026
Reiterates: Buy
Price Target: $58
Current: $37.73
Upside: +53.72%
Praxis Precision Medicines
Dec 29, 2025
Maintains: Buy
Price Target: $507 → $843
Current: $328.93
Upside: +156.29%
Rapport Therapeutics
Dec 8, 2025
Reiterates: Buy
Price Target: $47
Current: $29.20
Upside: +60.96%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $15.00
Upside: +53.33%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $26.71
Upside: -28.87%
EyePoint
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $14.36
Upside: +4.46%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.07
Upside: +367.29%